لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Li J; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lan Z; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liao W; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Horner JW; TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xu X; TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yoshihama Y; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jiang S; TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shim HS; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Slotnik M; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., LaBella KA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu CJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dunner K Jr; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hsu WH; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee R; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khanduri I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Terranova C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Akdemir K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chakravarti D; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shang X; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Spring DJ; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang YA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Indiana University, Indianapolis, IN, USA., DePinho RA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. RDePinho@mdanderson.org.

المصدر: Nature [Nature] 2023 Jul; Vol. 619 (7970), pp. 632-639. Date of Electronic Publication: 2023 Jun 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/metabolism , Colorectal Neoplasms*/pathology , Histone Demethylases*/genetics , Histone Demethylases*/metabolism , Minor Histocompatibility Antigens*/genetics , Minor Histocompatibility Antigens*/metabolism , Sex Characteristics*, Animals ; Female ; Humans ; Male ; Mice ; CD8-Positive T-Lymphocytes/immunology ; Disease Models, Animal ; Mice, Transgenic ; Up-Regulation

المؤلفون: Mokkapati S; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Narayan VM; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Manyam GC; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Lim AH; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Duplisea JJ; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Kokorovic A; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Miest TS; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Mitra AP; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Plote D; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Anand SS; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Metcalfe MJ; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Dunner K Jr; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Johnson BA; James Buchanan Brady Urological Institute, John Hopkins Greenberg Bladder Cancer Institute, John Hopkins University, School of Medicine, Baltimore, MD, USA., Czerniak BA; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Nieminen T; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Heikura T; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Yla-Herttuala S; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Parker NR; Middlesex, Hamesman, Ltd., Edgware, London, UK., Schluns KS; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., McConkey DJ; James Buchanan Brady Urological Institute, John Hopkins Greenberg Bladder Cancer Institute, John Hopkins University, School of Medicine, Baltimore, MD, USA., Dinney CP; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.

المصدر: Molecular therapy oncolytics [Mol Ther Oncolytics] 2022 Jun 10; Vol. 26, pp. 141-157. Date of Electronic Publication: 2022 Jun 10 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101666776 Publication Model: eCollection Cited Medium: Print ISSN: 2372-7705 (Print) Linking ISSN: 23727705 NLM ISO Abbreviation: Mol Ther Oncolytics Subsets: PubMed not MEDLINE

المؤلفون: Zhang Q; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Riley-Gillis B; AbbVie Inc., North Chicago, IL, USA., Han L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jia Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Lodi A; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Zhang H; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Ganesan S; Université de Paris, Institut de la Recherche Saint-Louis (IRSL), Inserm Unit 1131, Paris, France., Pan R; Dana-Farber Cancer Institute, Boston, MA, USA., Konoplev SN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sweeney SR; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Ryan JA; Dana-Farber Cancer Institute, Boston, MA, USA., Jitkova Y; Princess Margaret Cancer Center, Toronto, ON, Canada., Dunner K Jr; High Resolution Electron Microscopy Facility, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grosskurth SE; AbbVie Inc., North Chicago, IL, USA., Vijay P; AbbVie Inc., North Chicago, IL, USA., Ghosh S; AbbVie Inc., North Chicago, IL, USA., Lu C; AbbVie Inc., North Chicago, IL, USA., Ma W; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kurtz S; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Ruvolo VR; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weng CC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ramage CL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baran N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shi C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Hematology, The First Hospital Affiliated Harbin Medical University, Harbin, China., Cai T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davis RE; Department of Lymphoma & Myeloma Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Battula VL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mi Y; Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Wang J; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tyner JW; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Schimmer A; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Letai A; Dana-Farber Cancer Institute, Boston, MA, USA., Padua RA; Université de Paris, Institut de la Recherche Saint-Louis (IRSL), Inserm Unit 1131, Paris, France., Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tiziani S; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Leverson J; AbbVie Inc., North Chicago, IL, USA., Popovic R; AbbVie Inc., North Chicago, IL, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mkonople@mdanderson.org.

المصدر: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2022 Apr 01; Vol. 7 (1), pp. 110. Date of Electronic Publication: 2022 Apr 01.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Zhang Q; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Riley-Gillis B; AbbVie Inc., North Chicago, IL, USA., Han L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jia Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Lodi A; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Zhang H; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Ganesan S; Université de Paris, Institut de la Recherche Saint-Louis (IRSL), Inserm Unit 1131, Paris, France., Pan R; Dana-Farber Cancer Institute, Boston, MA, USA., Konoplev SN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sweeney SR; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Ryan JA; Dana-Farber Cancer Institute, Boston, MA, USA., Jitkova Y; Princess Margaret Cancer Center, Toronto, ON, Canada., Dunner K Jr; High Resolution Electron Microscopy Facility, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grosskurth SE; AbbVie Inc., North Chicago, IL, USA., Vijay P; AbbVie Inc., North Chicago, IL, USA., Ghosh S; AbbVie Inc., North Chicago, IL, USA., Lu C; AbbVie Inc., North Chicago, IL, USA., Ma W; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kurtz S; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Ruvolo VR; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weng CC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ramage CL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baran N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shi C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Hematology, The First Hospital Affiliated Harbin Medical University, Harbin, China., Cai T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davis RE; Department of Lymphoma & Myeloma Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Battula VL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mi Y; Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Wang J; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tyner JW; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Schimmer A; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Letai A; Dana-Farber Cancer Institute, Boston, MA, USA., Padua RA; Université de Paris, Institut de la Recherche Saint-Louis (IRSL), Inserm Unit 1131, Paris, France., Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tiziani S; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Leverson J; AbbVie Inc., North Chicago, IL, USA., Popovic R; AbbVie Inc., North Chicago, IL, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mkonople@mdanderson.org.

المصدر: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2022 Feb 21; Vol. 7 (1), pp. 51. Date of Electronic Publication: 2022 Feb 21.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

مواضيع طبية MeSH: Bridged Bicyclo Compounds, Heterocyclic*/pharmacology , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/metabolism , MAP Kinase Signaling System*/drug effects , Myeloid Cell Leukemia Sequence 1 Protein*/genetics , Myeloid Cell Leukemia Sequence 1 Protein*/metabolism , Proto-Oncogene Proteins c-bcl-2*/antagonists & inhibitors , Proto-Oncogene Proteins c-bcl-2*/genetics , Proto-Oncogene Proteins c-bcl-2*/metabolism , Sulfonamides*/pharmacology , ras Proteins*, Cell Line, Tumor ; Drug Resistance, Neoplasm ; Humans

المؤلفون: Verrico CD; Department of Psychiatry.; Department of Pharmacology, Baylor College of Medicine, Houston, TX, United States., Wesson S; Sunset Animal Hospital, Houston, TX, United States., Konduri V; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States., Hofferek CJ; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States., Vazquez-Perez J; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States., Blair E; Valimenta Labs, Fort Collins, CO, United States., Dunner K Jr; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, United States., Salimpour P; Boston University School of Medicine, Boston, MA, United States., Decker WK; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.; Center for Cell and Gene Therapy.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States., Halpert MM; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.

المصدر: Pain [Pain] 2020 Sep 01; Vol. 161 (9), pp. 2191-2202.

نوع المنشور: Journal Article; Randomized Controlled Trial, Veterinary; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7508686 Publication Model: Print Cited Medium: Internet ISSN: 1872-6623 (Electronic) Linking ISSN: 03043959 NLM ISO Abbreviation: Pain Subsets: MEDLINE

مواضيع طبية MeSH: Arthralgia*/drug therapy , Arthralgia*/veterinary , Cannabidiol*/therapeutic use , Osteoarthritis*/complications , Osteoarthritis*/drug therapy , Osteoarthritis*/veterinary , Dog Diseases*/drug therapy, Animals ; Dogs ; Mice ; Cannabis ; Double-Blind Method ; Disease Models, Animal